Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
There is a big push underway to try and resolve all of the Actos bladder cancer lawsuits. 
The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial scheduled in 2016.
In that trial at least five different cases may be consolidated for trial before one jury.
Actos Bladder Cancer Lawsuits Continue to Increase
Recently earlier this month, seventeen plaintiffs filed an Actos bladder cancer lawsuit against manufacturer Takeda Pharmaceuticals, blaming that the use of the type 2 diabetes treatment led to the diagnosis of bladder cancer.
Four of the plaintiffs had died from advanced bladder cancer. The other plaintiffs have experienced recurrences of their cancer, leading to complications and ongoing painful cancer treatments.
Plaintiffs Serious and Catastrophic Injuries From Actos
Zofran, is an anti-nausea medication that is commonly prescribed for morning sickness. However, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children.
GlaxoSmithKline Allegations
Patients have blamed GlaxoSmithKline’s failure to adequately research their medication or warn about the risk of congenital malformations. Injured children are filing Zofran birth defect lawsuits throughout the United States who have developed:
75,000 Women Cannot Be Wrong
Andrea Smith, received ASR hip implants on each side in October 2006 and February 2007. Smith’s blamed DePuy in her lawsuit, claiming that she had to undergo revision surgery to have the implants removed in 2011 and 2012, after being diagnosed with high levels of Cobalt and Chromium metal ions in her blood.
https://www.youtube.com/watch?feature=player_detailpage&v=BixcAewKQYg
Takeda Pharmaceutical Co. was ordered to pay more than $2.3 million in damages to a Pennsylvanian man who blamed the company’s Actos diabetes drug for causing his bladder cancer.
Judge Shelly Robins, from Pennsylvania has denied the appeal of a $2 million verdict awarded in October to a plaintiff who blamed Takeda Pharmaceuticals Inc.’s drug Actos was a significant contributor to her developing bladder cancer.
In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins New rejected the company’s post-trial motions, in which they had argued that the jury’s verdict overstepped the U.S. Food and Drug Administration’s authority.
The judge also added nearly $100,000 in delay damages, leading to a total judgment of $2.1 M.
This testimony was provided by David Kessler, the former head of the U.S. Food and Drug Administration, in the first case over the antipsychotic medication to be decided by a jury in state court in Philadelphia.
J&J, no stranger to governmental fines, has paid more than $2 billion to resolve a criminal probe over its drug Risperdal.
These are the first few settlements reached out of over twenty thousand personal injury cases filed against the Johnson & Johnson Ethicon subsidiary company.
These settlements were reached in state court claims, and included a one wrongful death claim that alleged the vaginal mesh caused a deadly infection.
There have been eight Actos Bladder Cancer trials to date across the United States. The majority of them have been held in various state courts and only one has been tried in the federal MDL out of thousands filed.According to court documents, Takeda knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warning until seven years later to protect billions of dollars in Actos sales.
Dallas Fort Worth Injury Lawyer Blog